Photopsia associated with camizestrant was mostly mild, nondisabling, and reversible, according to Adam Brufsky, MD, PhD, at SABCS 2025.
Adam Brufsky, MD, PhD
Advertisement
Articles by Adam Brufsky, MD, PhD
Adam Brufsky, MD, PhD, addresses how the COVID-19 pandemic affected breast cancer screening rates across Pittsburgh.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Clinicians Cite Progress Tracking as Top Barrier in Value-Based Care
2
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
3
Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19
4
Experts Warn Binge Drinking Drives Early-Onset Breast Cancer, While Cessation Reduces Risk
5
